Skip to main content
SpringerLink
Log in

Molecular and cellular mechanisms of donor cell-induced tolerance

  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

The induction of immunologic tolerance to solid organ allografts is a subject of intense investigation because of the morbidity and mortality associated with standard immunosuppressive therapy. One method that is currently in clinical and preclinical testing involves the transient ablation of recipient T cells using polyclonal antithymocyte sera or monoclonal anti-CD4/CD8 antibody treatment, followed by the posttransplant administration of donor bone marrow cells or of donor peripheral lymphoid populations. Recent studies in our laboratory have shown that the molecular and cellular basis of the prolongation of graft survival by donor cell administration depends on the cellular compartment from which the donor cells were derived. We provide here a brief review of these data followed by new data suggesting that the mode of peripheral and central selection is also dependent on the source from which the donor cells were derived.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Monaco AP, Wood ML, Maki T, Gozzo JJ. The use of donor-specific bone marrow to induce specific unresponsi viness (to lerance) to tissue allo grafts. Chimerism and Tolerance. K. J. Ildstad Ed., R. G. Landis, publisher 1995: 99–113.

  2. Musci MA, Latinis KM, Koretzky GA: Signaling events in T lymphocytes leading to cellular activation or programmed cell death. Clin Immunol Immunopathol 1997;83:205–222.

    Article  PubMed  CAS  Google Scholar 

  3. Reap EA, Piecyk ML, Oliver A, Sobel ES, Waldschmidt T, Cohen PL, Eisenberg RA. Phenotypic abnormalities of splemic and bone marrow B cells in 1pr and gld mice. Clin Immunol Immunopathol 1996;78:21–29.

    Article  PubMed  CAS  Google Scholar 

  4. Hahne M, Peitsch MC, Irmler M, Schroter M, Lowin B, Rousseau M, Bron C, Renno T, French L, Tschopp J: Characterization of the non-functional Fas ligand of gld mice. Int Immunol 1995;7:1381–1386.

    Article  PubMed  CAS  Google Scholar 

  5. George JF, Sweeney SD, Goldstein DR, Kirklin JK, Thomas JM. An essential role for fas-ligand in transplantation to lerance. Nat Med 1998;4:333–335.

    Article  PubMed  CAS  Google Scholar 

  6. Adachi M, Watanabe-Fukunaga R, Nagata S: Aberrant transcription caused by the insertion of an early transposable element in an intron of theFasantigen gene of lprmice. Proc. Natl Acad Sci USA 1993; 90:1756–1760.

    Article  PubMed  CAS  Google Scholar 

  7. Goldstein DR, Thomas JM, Kirklin JK, George JF: Indefinite allograft survival mediated by donor bone marrow is dependent on the presence of a functional CD95 (Fas) gene in recipients. J Heart Lung Transpl 2001;20(10):1132–1135.

    Article  CAS  Google Scholar 

  8. Goldstein DR, Chang T, Sweeney SD, Kirklin JK, Thomas JM, George JF. Enhancedallograft survival induced by postransplant donor spleen cell infusion occurs via a mechanism of enhancement by donor bone marrow. Transplantation 2000;69:1020–1022.

    Article  PubMed  CAS  Google Scholar 

  9. Kronin V, Vremec D, Winkel K, Classon BJ, Miller RG, Mak TW, Shortman K, Suss G: Are CD8+ dendritic cells (DC) veto cells? The role of CD8 on DC in DC development and in the regulation of CD4 and CD8 T cell responses. Intl Immunol 1997;9:1061–1064.

    Article  CAS  Google Scholar 

  10. Zhang L, Shannon J, Sheldon J, Teh HS, Mak TW, Miller RG: Role of infused CD8+ cells in the induction of peripheral to lerance. J Immunol 1994;152:2222–2228

    PubMed  CAS  Google Scholar 

  11. Sambhara SR and Miller RG: Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class 1 MHC. Science 1991;252:1424–1427.

    Article  PubMed  CAS  Google Scholar 

  12. Thomas JM, Carver FM, Kasten-Jolly J, Haisch CE, Rebellato LM, Gross U, Vore SJ, Thomas FT: Further studies of veto activity in rehesus monkey bone marrow in relation to allograft tolerance and chimersim. Transplantation 1994; 57:101–115.

    Article  PubMed  CAS  Google Scholar 

  13. Thomas JM, Verbanac KM, Carver FM, Kasten-Jolly J, Haisch CE, Gross U, Smith JP: Veto cells in transplantation to lerance. Clin Transplantation 1993;8:195–203.

    Google Scholar 

  14. Thomas JM, Carver FM, Cuningham PR, Olson LC, Thomas FT: Kidney allograft tolerance in primates without chronic immuno-suppression-the role of veto cells. Transplantation 1991;51:198–207.

    Article  PubMed  CAS  Google Scholar 

  15. Goldstein DR, Chang T, Sweeney SD, Kirklin JK, Thomas JM, George JF: A differential requirement for CD8+donor cells in the augmentation of allograft survival by posttransplantation administration of donor spleen cells and donor bone marrow cells. Transplantation 2000;70(7):1068–1073.

    Article  PubMed  CAS  Google Scholar 

  16. Muraoka S and Miller RG: Cells in bone marrow and in T cell colonies grown from bone marrow can suppress generation of cytotoxic T lymphocytes directed against their self antigens. J Exp Med 1980;152:54–71.

    Article  PubMed  CAS  Google Scholar 

  17. Asai O, Longo DL, Tian ZG, Hornung RL, Taub DD, Ruscetti FW, Murphy WJ: Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest 1998; 101:1835–1842

    Article  PubMed  CAS  Google Scholar 

  18. Zeng D, Lewis D, Dejbakhsh-Jones S, Lan F, Garcia-Ojeda M, Sibley R, Strober S: Bone marrow NK 1.1(−) and NK 1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med 1999;189:1073–1081.

    Article  PubMed  CAS  Google Scholar 

  19. Sonoda KH, Exley M, Snapper S, Balk SP, Stein-Streilein J: CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J Exp Med 1999;190:1215–1226.

    Article  PubMed  CAS  Google Scholar 

  20. Cassell DJ, Forman J: Regulation of the cytotoxic T lymphocyte response against Qa-1 alloantigens. J Immunol 1990;144:4075–4081.

    PubMed  CAS  Google Scholar 

  21. Roder JC: The beige mutation in the mouse: I. A stem cell predetermined impairment in natural killer cell function. J Immunol 1979;123:2168–2173.

    PubMed  CAS  Google Scholar 

  22. Clark EA, Shultz LD, Pollack SB: Mutations in mice that infuence natural killer (NK) activity. Immunogenetics 1981;12:601–613.

    Article  PubMed  CAS  Google Scholar 

  23. Goldstein DR, Thomas JM, Kirklin JK, George JF: An essential role for natural killer cells in augmentation of allograft survival mediated by donor spleen cells. Transplantation 2001;72:954–956.

    Article  PubMed  CAS  Google Scholar 

  24. Murphy WJ, Bennett M, Kumar V, Longo DL: Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantation. J Immunol 1992;148:2953–2960

    PubMed  CAS  Google Scholar 

  25. Murphy WJ, Koh CY, Raziuddin A, Bennett M, Longo DL: Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies. Immunol Rev 2001;181:279–289

    Article  PubMed  CAS  Google Scholar 

  26. Zhang L, Martin DR, Fung-Leung WP, Teh HS, Miller RG: Peripheral deletion of mature CD8+antigen-specific T cells after in vivo exposure to male antigen. J Immunol 1992;148:3740–3745.

    PubMed  CAS  Google Scholar 

  27. Kisielow P, Blutlmmann H, Staerz UD, Steinmetz M, von Boehmer H: Tolerance in T cell receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 1988;333:742–746.

    Article  PubMed  CAS  Google Scholar 

  28. Teh H, Kishi H, Scott B, von Boehmer H: Deletion of autospecific T cells in T cell receptor (TCR) transgenic mice spares cells with normal TCR levels and low levels of CD8 molecules. J Exp Med 1989;169:795–806.

    Article  PubMed  CAS  Google Scholar 

  29. Staerz UD, Rammensee HG, Bendetto JD, Bevan MJ. Characterization of a monoclonal antibody specific for an allotypic determinant on the T cell antigen receptor. J Immunol 1985;134:3994–4000.

    PubMed  CAS  Google Scholar 

  30. Miller RG, Derry H: A cell population in nu/nu spleen can prevent generation of cytotoxic lymphocytes by normal spleen cells aginst self antigens of the nu/nu spleen. J Immunol 1979;122:1502–1509.

    PubMed  CAS  Google Scholar 

  31. Miller RG, Muraoka S, Claesson MH, Reimann J, Benveniste P: The veto phenomenon in T-cell regulation. Am NY Acad Sci 1988;532:170–176.

    Article  CAS  Google Scholar 

  32. Gozzo JJ, Wood ML, Moraco AP: Use of allo genic, homozygous bone marrow cells for the induction of specific immunologic tolerance in mice treated with antilymphocyte serum. Surgi Forum 1970;21:281–284.

    CAS  Google Scholar 

  33. Monaco AP and Wood ML: Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum. Transplantation Proc 1970;2:489–496.

    CAS  Google Scholar 

  34. Thomas JM, Carver FM, Foil MB, Hall WR, Adams C, Fahrenbruch GBTFT: Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys. Transplantation 1983; 36:104–106.

    Article  PubMed  CAS  Google Scholar 

  35. Zhang L, Fung-Leung W, Miller RG: Down-regulation of CD8 on mature antigen-reactive T cells as a mechanism of peripheral tolerance. J Immunol 1995;155:3464–3471.

    PubMed  CAS  Google Scholar 

  36. Teh HS, Kisielow P, Scott B, Kishi H, Uematsu Y, Bluthmann H, von Boehmer H: Thymic major histocompatibility complex antigens and the alphabeta T cell receptor determine the CD4/CD8 phenotype of T cells. Nature 1988;335:229–233.

    Article  PubMed  CAS  Google Scholar 

  37. Rocha B, von Boehmer H: Peripheralselection of the T cell repertoire. Science 1991;251:1225–1228.

    Article  PubMed  CAS  Google Scholar 

  38. Seaman MN, Burd CG, Enr SD: Receptor signalling and the regulation of endocytic membrane transport. Curr Opin Cell Biol 1996;8:549–556.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Division of Cardiothoracic Surgery, University of Alabama at Birmingham, 35294-0007, Birmingham, AL

    James F. George PhD, Leonik Ahumada & Ailing Lu

Authors
  1. James F. George PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leonik Ahumada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ailing Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James F. George PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

George, J.F., Ahumada, L. & Lu, A. Molecular and cellular mechanisms of donor cell-induced tolerance. Immunol Res 26, 119–129 (2002). https://doi.org/10.1385/IR:26:1-3:119

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/IR:26:1-3:119

Key Words

Search

Navigation